Magazine Article | February 1, 2019

BeiGene Exec Talks Candidly About Quality, Compliance, And Outsourcing

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma
Follow Me On Twitter @Louis_Garguilo

It was time within our greater ruminations on China (see outsourcedpharma.com) to speak directly with a quality executive at a drug developer and manufacturer based there. That’s now been accomplished via a discussion with Diana Francis, VP of quality and compliance for BeiGene.

BeiGene is a biopharma developing and commercializing cancer drugs for global markets. It has been dubbed as a potential “Genentech of China.” The company also has locations in the U.S., Australia, and Europe.